Ghalekhani Nima, Mirzazadeh Ali, Tavakoli Fatemeh, Mousavian Ghazal, Khezri Mehrdad, Zamani Omid, Mehmandoost Soheil, Haghdoost Ali Akbar, Sharifi Hamid
Nima Ghalekhani, PhD, is a Research vice chancellor of HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Ali Mirzazadeh, PhD, is an Assistant Professor of Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA, and HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Fatemeh Tavakoli, MSc, is a PhD Candidate, who is a Research Assistant at HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Ghazal Mousavian MSc, is a PhD Candidate, who is a Research Assistant at HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Mehrdad Kherzi, MSc, is a PhD Candidate, who is a Research Assistant at HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Omid Zamani, MD, MPH, is a Research assistant at HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Soheil Mehmandoost, MSc, is a PhD Candidate, who is a Research Assistant at HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Ali Akbar Haghdoost, PhD, is a Professor of Epidemiology, Head of the Institute for Futures Studies in Health Kerman University of Medical Sciences, HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Kerman, Iran. Hamid Sharifi, PhD, is a Professor of Epidemiology, Head of HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
J Assoc Nurses AIDS Care. 2023;34(2):182-187. doi: 10.1097/JNC.0000000000000391. Epub 2023 Jan 18.
People living with HIV who inject drugs may have lower access to treatment services. We aimed to assess the HIV continuum of care among people who inject drugs (PWID) in Iran. Data were collected from 2,663 PWID who were recruited via respondent-driven sampling from 11 cities of Iran between June 2019 and March 2020. Participants who tested positive for HIV infection were asked questions to calculate the status of HIV cascade of care. Of 95 PWID living with HIV, 67% were aware of their HIV status, 57% were linked to care service and initiated ART, 49% retained on ART, and only 15% had viral load less than 1,000 copies/ml. About half of the PWID diagnosed with HIV ever started ART and less than one in six were virally suppressed. Strategies to improve linkage to ART programs and ART retention may improve HIV care outcomes among PWID in Iran.
注射毒品的艾滋病病毒感染者获得治疗服务的机会可能较低。我们旨在评估伊朗注射毒品者（PWID）的艾滋病病毒连续护理情况。2019年6月至2020年3月期间，通过应答者驱动抽样从伊朗11个城市招募了2663名注射毒品者，并收集了相关数据。对检测出艾滋病病毒感染呈阳性的参与者进行提问，以计算艾滋病病毒护理级联的状况。在95名感染艾滋病病毒的注射毒品者中，67%知晓自己的艾滋病病毒感染状况，57%与护理服务机构建立联系并开始接受抗逆转录病毒治疗（ART），49%持续接受ART治疗，只有15%的病毒载量低于1000拷贝/毫升。约一半被诊断出感染艾滋病病毒的注射毒品者曾开始接受ART治疗，不到六分之一的人实现了病毒抑制。改善与ART项目的联系及提高ART治疗留存率的策略，可能会改善伊朗注射毒品者的艾滋病病毒护理结果。
